The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126136824 12613682 4 F 20160829 20160802 20160831 EXP JP-009507513-1608JPN000043 MERCK 60.00 YR M Y 0.00000 20160831 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126136824 12613682 1 PS ESLAX INTRAVENOUS 25MG/2.5ML ROCURONIUM BROMIDE 1 Intravenous (not otherwise specified) 35 MG, QD 20214 35 MG SOLUTION FOR INJECTION QD
126136824 12613682 2 SS PROPOFOL. PROPOFOL 1 Parenteral 70 MG, QD 0 70 MG INFUSION QD
126136824 12613682 3 SS REMIFENTANIL HYDROCHLORIDE REMIFENTANIL HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0.4/MCG/KG/MIN, DAILY DOSE UNKNOWN U 0 INJECTION
126136824 12613682 4 SS REMIFENTANIL HYDROCHLORIDE REMIFENTANIL HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0.1/MCG/KG/MIN, DAILY DOSE UNKNOWN U 0 INJECTION
126136824 12613682 5 C CLOPIDOGREL CLOPIDOGREL BISULFATE 1 Oral 75 MG, QD. DIVIDED DOSE, FREQUENCY UNKNOWN 0 75 MG ORAL POWDER QD
126136824 12613682 6 C SEVOFLURANE. SEVOFLURANE 1 Respiratory (inhalation) 0.5 %, DAILY DOSE UNKNOWN 0 INHALATION VAPOUR, SOLUTION
126136824 12613682 7 C SEVOFLURANE. SEVOFLURANE 1 Respiratory (inhalation) 0.6 %, DAILY DOSE UNKNOWN 0 INHALATION VAPOUR, SOLUTION
126136824 12613682 8 C SEVOFLURANE. SEVOFLURANE 1 Respiratory (inhalation) 0.5 %, DAILY DOSE UNKNOWN 0 INHALATION VAPOUR, SOLUTION
126136824 12613682 9 C EPHEDRINE HYDROCHLORIDE EPHEDRINE HYDROCHLORIDE 1 Parenteral 5MG X 5 TIMES, DAILY DOSE UNKNOWN 0 15 MG INJECTION
126136824 12613682 10 C EPHEDRINE HYDROCHLORIDE EPHEDRINE HYDROCHLORIDE 1 Parenteral 10 MG X TWICE, DAILY DOSE UNKNOWN 0 20 MG INJECTION
126136824 12613682 11 C NEOSYNESIN PHENYLEPHRINE HYDROCHLORIDE 1 Parenteral 0.1 MG X 3 TIMES, DAILY DOSE UNKNOWN 0 .3 MG INJECTION
126136824 12613682 12 C NEOSYNESIN PHENYLEPHRINE HYDROCHLORIDE 1 Parenteral 0.2 MG, ONCE 0 .2 MG INJECTION 1X
126136824 12613682 13 C NEOSYNESIN PHENYLEPHRINE HYDROCHLORIDE 1 Parenteral 0.3 MG, ONCE 0 .3 MG INJECTION 1X
126136824 12613682 14 C ATROPINE SULFATE. ATROPINE SULFATE 1 Parenteral 0.5 MG, ONCE 0 .5 MG INJECTION 1X
126136824 12613682 15 C DOPAMINE DOPAMINEDOPAMINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 3MCG/KG/MIN, DAILY DOSE UNKNOWN 0 INJECTION
126136824 12613682 16 C DOPAMINE DOPAMINEDOPAMINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 5MCG/KG/MIN, DAILY DOSE UNKNOWN 0 INJECTION
126136824 12613682 17 C TELMISARTAN. TELMISARTAN 1 Oral DAILY DOSAGE UNKNOWN 0 ORAL POWDER

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126136824 12613682 1 Neuromuscular blocking therapy
126136824 12613682 2 Induction of anaesthesia
126136824 12613682 3 Induction of anaesthesia
126136824 12613682 6 Maintenance of anaesthesia
126136824 12613682 17 Hypertension

Outcome of event

Event ID CASEID OUTC COD
126136824 12613682 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126136824 12613682 Arteriospasm coronary
126136824 12613682 Cardiac arrest

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found